LENZ Therapeutics Statistics

Total Valuation

LENZ has a market cap or net worth of $836.07 million. The enterprise value is $634.85 million.

Market Cap	836.07M
Enterprise Value	634.85M

Important Dates

The last earnings date was Wednesday, November 5, 2025, before market open.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

LENZ has 31.29 million shares outstanding. The number of shares has increased by 87.55% in one year.

Current Share Class	31.29M
Shares Outstanding	31.29M
Shares Change (YoY)	+87.55%
Shares Change (QoQ)	+1.64%
Owned by Insiders (%)	2.52%
Owned by Institutions (%)	80.99%
Float	20.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	42.64
Forward PS	26.82
PB Ratio	3.94
P/TBV Ratio	4.31
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	36.28
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.69, with a Debt / Equity ratio of 0.00.

Current Ratio	12.69
Quick Ratio	12.46
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -28.78% and return on invested capital (ROIC) is -20.61%.

Return on Equity (ROE)	-28.78%
Return on Assets (ROA)	-19.52%
Return on Invested Capital (ROIC)	-20.61%
Return on Capital Employed (ROCE)	-34.93%
Revenue Per Employee	$1.59M
Profits Per Employee	-$5.35M
Employee Count	11
Asset Turnover	0.08
Inventory Turnover	n/a

Taxes

In the past 12 months, LENZ has paid $501,000 in taxes.

Income Tax	501,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.43% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-25.43%
50-Day Moving Average	33.51
200-Day Moving Average	31.16
Relative Strength Index (RSI)	41.69
Average Volume (20 Days)	966,703

Short Selling Information

The latest short interest is 8.56 million, so 27.37% of the outstanding shares have been sold short.

Short Interest	8.56M
Short Previous Month	7.23M
Short % of Shares Out	27.37%
Short % of Float	42.71%
Short Ratio (days to cover)	6.26

Income Statement

In the last 12 months, LENZ had revenue of $17.50 million and -$58.88 million in losses. Loss per share was -$2.11.

Revenue	17.50M
Gross Profit	17.50M
Operating Income	-67.90M
Pretax Income	-58.38M
Net Income	-58.88M
EBITDA	-67.70M
EBIT	-67.90M
Loss Per Share	-$2.11

Full Income Statement

Balance Sheet

The company has $202.17 million in cash and $954,000 in debt, giving a net cash position of $201.22 million or $6.43 per share.

Cash & Cash Equivalents	202.17M
Total Debt	954,000
Net Cash	201.22M
Net Cash Per Share	$6.43
Equity (Book Value)	193.93M
Book Value Per Share	6.78
Working Capital	190.68M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$45.22 million and capital expenditures -$938,000, giving a free cash flow of -$46.16 million.

Operating Cash Flow	-45.22M
Capital Expenditures	-938,000
Free Cash Flow	-46.16M
FCF Per Share	-$1.48

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-388.00%
Pretax Margin	-333.61%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LENZ does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-87.55%
Shareholder Yield	-87.55%
Earnings Yield	-7.04%
FCF Yield	-5.52%

Dividend Details

Analyst Forecast

The average price target for LENZ is $56.25, which is 110.52% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$56.25
Price Target Difference	110.52%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LENZ has an Altman Z-Score of 28.63 and a Piotroski F-Score of 1.

Altman Z-Score	28.63
Piotroski F-Score	1